Talaris Therapeutics, Inc. (TALS): Price and Financial Metrics

Talaris Therapeutics, Inc. (TALS): $27.20

0.20 (-0.73%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add TALS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#127 of 360

in industry

TALS Price/Volume Stats

Current price $27.20 52-week high $27.95
Prev. close $2.74 52-week low $0.89
Day low $26.90 Volume 30,520
Day high $27.95 Avg. volume 386,531
50-day MA $2.83 Dividend yield N/A
200-day MA $2.41 Market Cap 1.16B

TALS Stock Price Chart Interactive Chart >


Talaris Therapeutics, Inc. (TALS) Company Bio


Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, and metabolic disorders. Its lead product candidate is FCR001, a novel allogeneic cell therapy that is in Phase II trial for living donor kidney transplant patients. The company is also developing FCR002 in deceased donor kidney transplants; FCR001 in patients with a severe form of scleroderma; and FCR001 for one or more severe non-malignant blood, immune, or metabolic disorders. Talaris Therapeutics, Inc. was founded in 1988 and is headquartered in Louisville, Kentucky.


TALS Latest News Stream


Event/Time News Detail
Loading, please wait...

TALS Latest Social Stream


Loading social stream, please wait...

View Full TALS Social Stream

TALS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -77.67%
5-year N/A
YTD N/A
2023 0.00%
2022 -93.33%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!